4
Changes in Ownership
BioXcel Therapeutics, Inc. Filed Acc 0001104659-23-033403
CEO and President acquired 10,437 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mehta Vimal CEO and President | 2023-03-14 | Option exercise | +10,437 | 20,394 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Mehta Vimal CEO and President | 2023-03-14 | Option exercise · Restricted Stock Units | −10,437 | 31,313 | D: show line 2 in the form | |||||
| Mehta Vimal CEO and President | 2023-03-15 | Grant or award · Restricted Stock Units | +56,000 | 56,000 | D: show line 3 in the form | |||||
| Mehta Vimal CEO and President | 2023-03-15 | Grant or award · Stock Option (Right to Buy) | +168,000 | 168,000 | D: show line 4 in the form |
Loading xslF345X03/tm239796-4_4seq1.xml…